ClinicalTrials.Veeva

Menu

Quit and Screen Project

University of Arkansas logo

University of Arkansas

Status

Begins enrollment this month

Conditions

Knowledge
Behavioral Intention
Attitudes

Treatments

Other: G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training
Other: Quit and Screen Project training

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06350643
P50MD017319-03S1 (U.S. NIH Grant/Contract)
287064

Details and patient eligibility

About

The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.

The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.

Full description

This clinical trial tests the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition.

In partnership with the National Medical Association, investigators will recruit 300 healthcare providers who provide clinical services to individuals who smoke smoke. Interested providers will be screened; if eligible, the will complete informed consent. Providers who complete the online consent and agree to enroll in the training study will be individually randomized to one of 2 conditions: The Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training. After randomization, providers will complete a pre-test assessing their knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography. Providers will then complete an online training. Providers will then complete a post-test assessing their 1) knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography and 2) preferences for the online materials and satisfaction with the training. Feasibility will be assessed using data on provider interest in the training and training reach.

Enrollment

300 estimated patients

Sex

All

Ages

21 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Current National Medical Association (NMA) member
  • Serves a patient clientele who smokes
  • At least 20% of time (1 day per week) devoted to clinical care
  • Currently screens clients for tobacco use in the clinic
  • Have the capacity to refer smokers to a patient navigator
  • Willing to provide informed consent
  • Will provide contact email, address and phone.

Exclusion criteria

  • None

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 2 patient groups

Quit and Screen Project training alone
Experimental group
Description:
Providers in this arm will only complete the Quit and Screen Project training. This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training .
Treatment:
Other: Quit and Screen Project training
Quit and Screen Project training + G02 Lung Cancer Screening training
Experimental group
Description:
In this arm, providers will complete the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training and the Quit and Screen Project training. The Quit and Screen Project training is an online course being developed to fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 Lung Cancer Screening training.
Treatment:
Other: Quit and Screen Project training
Other: G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

Trial contacts and locations

1

Loading...

Central trial contact

Mignonne Guy, PhD; Ashley Clawson, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems